Your browser doesn't support javascript.
COVID-19 reinfection in the presence of neutralizing antibodies.
Zhang, Ju; Ding, Nan; Ren, Lili; Song, Rui; Chen, Danying; Zhao, Xuesen; Chen, Budong; Han, Junyan; Li, Jiarui; Song, Yangzi; Di, Lin; Han, Kai; Yu, Fengting; Xie, Ruming; Chen, Zhihai; Xie, Wen; Liu, Jingyuan; Cen, Shan; Bi, Yuhai; Wu, Angela R; Zhang, Fujie; Chen, Chen; Zeng, Hui.
  • Zhang J; Beijing Ditan Hospital, Capital Medical University, China.
  • Ding N; Beijing Ditan Hospital, Capital Medical University, China.
  • Ren L; NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, China.
  • Song R; Beijing Ditan Hospital, Capital Medical University, China.
  • Chen D; Beijing Ditan Hospital, Capital Medical University, China.
  • Zhao X; Beijing Ditan Hospital, Capital Medical University, China.
  • Chen B; Beijing Ditan Hospital, Capital Medical University, China.
  • Han J; Beijing Ditan Hospital, Capital Medical University, China.
  • Li J; Beijing Ditan Hospital, Capital Medical University, China.
  • Song Y; Beijing Ditan Hospital, Capital Medical University, China.
  • Di L; Beijing Advanced Innovation Center for Genomics, Biomedical Pioneering Innovation Center, Peking University, China.
  • Han K; Beijing Ditan Hospital, Capital Medical University, China.
  • Yu F; Beijing Ditan Hospital, Capital Medical University, China.
  • Xie R; Beijing Ditan Hospital, Capital Medical University, China.
  • Chen Z; Beijing Ditan Hospital, Capital Medical University, China.
  • Xie W; Beijing Ditan Hospital, Capital Medical University, China.
  • Liu J; Beijing Ditan Hospital, Capital Medical University, China.
  • Cen S; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical School, China.
  • Bi Y; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, China.
  • Wu AR; Division of Life Science and Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, China.
  • Zhang F; Beijing Ditan Hospital, Capital Medical University, China.
  • Chen C; Beijing Ditan Hospital, Capital Medical University, China.
  • Zeng H; Beijing Ditan Hospital, Capital Medical University, China.
Natl Sci Rev ; 8(4): nwab006, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1254806
ABSTRACT
After a short recovery period, COVID-19 reinfections could occur in convalescent patients, even those with measurable levels of neutralizing antibodies. Effective vaccinations and protective public health measures are recommended for the convalescent COVID-19 patients.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Natl Sci Rev Year: 2021 Document Type: Article Affiliation country: Nsr

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Natl Sci Rev Year: 2021 Document Type: Article Affiliation country: Nsr